These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10411659)

  • 81. [3H]cholesterol transfer from microemulsion particles of different sizes to human fibroblasts.
    Ekman S
    Lipids; 1987 Sep; 22(9):657-63. PubMed ID: 3669928
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Alternative pathways in the biosynthesis of sphingomyelin and the role of phosphatidylcholine, CDPcholine and phosphorylcholine as precursors.
    Marggraf WD; Anderer FA
    Hoppe Seylers Z Physiol Chem; 1974 Jul; 355(7):803-10. PubMed ID: 4474135
    [No Abstract]   [Full Text] [Related]  

  • 83. Isolation of plasma membranes from cultured glioma cells and application to evaluation of membrane sphingomyelin turnover.
    Cook HW; Palmer FB; Byers DM; Spence MW
    Anal Biochem; 1988 Nov; 174(2):552-60. PubMed ID: 3239757
    [TBL] [Abstract][Full Text] [Related]  

  • 84. 2-Hydroxy-oleic acid does not activate sphingomyelin synthase activity.
    Lou B; Liu Q; Hou J; Kabir I; Liu P; Ding T; Dong J; Mo M; Ye D; Chen Y; Bui HH; Roth K; Cao Y; Jiang XC
    J Biol Chem; 2018 Nov; 293(47):18328-18336. PubMed ID: 30305392
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Compartmentalized production of ceramide at the cell surface.
    Liu P; Anderson RG
    J Biol Chem; 1995 Nov; 270(45):27179-85. PubMed ID: 7592974
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The effect of three serum basic proteins on the mass of lipids in normal and hyperapoB fibroblasts.
    Kwiterovich PO; Motevalli M; Miller M
    Arterioscler Thromb; 1994 Jan; 14(1):1-7. PubMed ID: 8274464
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Decreased cholesterol biosynthesis in fibroblasts from patients with Parkinson disease.
    Musanti R; Parati E; Lamperti E; Ghiselli G
    Biochem Med Metab Biol; 1993 Apr; 49(2):133-42. PubMed ID: 8484956
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Lovastatin reversed the enhanced sphingomyelin caused by 27-hydroxycholesterol in cultured vascular endothelial cells.
    Zhou Q; Luo A; Kummerow FA
    Biochem Biophys Rep; 2016 Mar; 5():127-133. PubMed ID: 28955814
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Imipramine Treatment Alters Sphingomyelin, Cholesterol, and Glycerophospholipid Metabolism in Isolated Macrophage Lysosomes.
    Albright JM; Sydor MJ; Shannahan J; Ferreira CR; Holian A
    Biomolecules; 2023 Dec; 13(12):. PubMed ID: 38136603
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Predicting coordinated lipid biosynthesis: application to the surfactant-accommodated epidermis.
    Ando HY; Gazdick GG; Sugita ET; Schnaare RL
    Lipids; 1988 Nov; 23(11):1073-8. PubMed ID: 3237008
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Improved separation of radioactively labelled cellular phospholipids by high-performance liquid chromatography.
    Trümbach B; Rogler G; Lackner KJ; Schmitz G
    J Chromatogr B Biomed Appl; 1994 Jun; 656(1):73-6. PubMed ID: 7952049
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Phosphatidylcholine: Greasing the Cholesterol Transport Machinery.
    Lagace TA
    Lipid Insights; 2015; 8(Suppl 1):65-73. PubMed ID: 27081313
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Role of Neutral Sphingomyelinase-2 (NSM 2) in the Control of T Cell Plasma Membrane Lipid Composition and Cholesterol Homeostasis.
    Börtlein C; Schumacher F; Kleuser B; Dölken L; Avota E
    Front Cell Dev Biol; 2019; 7():226. PubMed ID: 31681760
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The connection between C-reactive protein and atherosclerosis.
    Singh SK; Suresh MV; Voleti B; Agrawal A
    Ann Med; 2008; 40(2):110-20. PubMed ID: 18293141
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Interleukin-1 (IL-1) pathway.
    Weber A; Wasiliew P; Kracht M
    Sci Signal; 2010 Jan; 3(105):cm1. PubMed ID: 20086235
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Increased serum levels of interleukin-1beta in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients?
    Dalekos GN; Elisaf M; Bairaktari E; Tsolas O; Siamopoulos KC
    J Lab Clin Med; 1997 Mar; 129(3):300-8. PubMed ID: 9042815
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Efficacy and safety of the human anti-IL-1β monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, Phase II, dose-finding study.
    Alten R; Gomez-Reino J; Durez P; Beaulieu A; Sebba A; Krammer G; Preiss R; Arulmani U; Widmer A; Gitton X; Kellner H
    BMC Musculoskelet Disord; 2011 Jul; 12():153. PubMed ID: 21736751
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Mechanisms of interleukin-1beta release.
    Eder C
    Immunobiology; 2009; 214(7):543-53. PubMed ID: 19250700
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment.
    Libby P; Ridker PM
    Am J Med; 2004 Mar; 116 Suppl 6A():9S-16S. PubMed ID: 15050187
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Function of C-reactive protein.
    Du Clos TW
    Ann Med; 2000 May; 32(4):274-8. PubMed ID: 10852144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.